Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair

被引:89
作者
Fiane, AE [1 ]
Videm, V
Lingaas, PS
Heggelund, L
Nielsen, EW
Geiran, OR
Fung, M
Mollnes, TE
机构
[1] Rikshosp Univ Hosp, Dept Thorac & Cardiovasc Surg, Internal Med Res Inst, N-0027 Oslo, Norway
[2] Rikshosp Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway
[3] Rikshosp Univ Hosp, Inst Immunol, N-0027 Oslo, Norway
[4] Norwegian Univ Sci & Technol, Inst Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
[5] Univ Trondheim Hosp, Dept Immunol & Transfus Med, Trondheim, Norway
[6] Nordland Hosp, Dept Anesthesiol, Bodo, Norway
[7] Univ Tromso, N-9001 Tromso, Norway
[8] Tanox Inc, Houston, TX USA
关键词
ischemia; reperfusion; aneurysm; cytokines; inflammation;
D O I
10.1161/01.CIR.0000084550.16565.01
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background-Complement activation contributes to ischemia-reperfusion injury. Patients undergoing thoracoabdominal aortic aneurysm (TAAA) repair suffer extensive ischemia-reperfusion and considerable systemic inflammation. Methods and Results-The degree and mechanism of complement activation and its role in inflammation were investigated in 19 patients undergoing TAAA repair. Patients undergoing open infrarenal aortic surgery (n=5) or endovascular descending aortic aneurysm repair (n=6) served as control subjects. Substantial complement activation was seen in TAAA patients but not in controls. C1rs-C1-inhibitor complexes increased moderately, whereas C4bc, C3bBbP, C3bc, and the terminal SC5b-9 complex (TCC) increased markedly after reperfusion, reaching a maximum 8 hours after reperfusion. Interleukin (IL)-1beta, tumor necrosis factor alpha(TNF-alpha), and IL-8 increased significantly in TAAA patients but not in controls, peaking at 24 hours postoperatively and correlating closely with the degree of complement activation. IL-6 and IL-10 increased to a maximum 8 hours after reperfusion in the TAAA patients, were not correlated with complement activation, and increased moderately in the control subjects. Myeloperoxidase and lactoferrin increased markedly before reperfusion in all groups, whereas sICAM-1, sP-selectin, and sE-selectin were unchanged. No increase was observed in complement activation products, IL-1beta, TNF-alpha, or IL-8 in a mannose-binding lectin (MBL)-deficient TAAA patient, whereas IL-6, IL-10, myeloperoxidase, and lactoferrin increased as in the controls. Two other MBL-deficient TAAA patients receiving plasma attained significant MBL levels and showed complement and cytokine patterns identical to the MBL-sufficient TAAA patients. Conclusions-The data suggest that complement activation during TAAA repair is MBL mediated, amplified through the alternative pathway, and responsible in part for the inflammatory response.
引用
收藏
页码:849 / 856
页数:8
相关论文
共 33 条
[1]
Ischemia/reperfusion injury [J].
Anaya-Prado, R ;
Toledo-Pereyra, LH ;
Lentsch, AB ;
Ward, PA .
JOURNAL OF SURGICAL RESEARCH, 2002, 105 (02) :248-258
[2]
SEPARATION OF SELF FROM NON-SELF IN THE COMPLEMENT-SYSTEM [J].
ATKINSON, JP ;
FARRIES, T .
IMMUNOLOGY TODAY, 1987, 8 (7-8) :212-215
[3]
Ischemia-reperfusion injury [J].
Boyle, EM ;
Pohlman, TH ;
Cornejo, CJ ;
Verrier, ED .
ANNALS OF THORACIC SURGERY, 1997, 64 (04) :S24-S30
[4]
CARDIOPROTECTIVE EFFECTS OF A C1 ESTERASE INHIBITOR IN MYOCARDIAL-ISCHEMIA AND REPERFUSION [J].
BUERKE, M ;
MUROHARA, T ;
LEFER, AM .
CIRCULATION, 1995, 91 (02) :393-402
[5]
Complement activation after oxidative stress -: Role of the lectin complement pathway [J].
Collard, CD ;
Väkevä, A ;
Morrissey, MA ;
Agah, A ;
Rollins, SA ;
Reenstra, WR ;
Buras, JA ;
Meri, S ;
Stahl, GL .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (05) :1549-1556
[6]
COSELLI JS, 1999, CARDIOL CLIN N AM, V4, P751
[7]
Strategies for targeting complement inhibitors in ischaemia/reperfusion injury [J].
Dong, J ;
Pratt, JR ;
Smith, RAG ;
Dodd, I ;
Sacks, SH .
MOLECULAR IMMUNOLOGY, 1999, 36 (13-14) :957-963
[8]
Endotoxin related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurysm repair [J].
Foulds, S ;
Cheshire, NJ ;
Schachter, M ;
Wolfe, JH ;
Mansfield, AO .
BRITISH JOURNAL OF SURGERY, 1997, 84 (02) :172-177
[9]
A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s [J].
Fure, H ;
Nielsen, EW ;
Hack, CE ;
Mollnes, TE .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (06) :553-557
[10]
QUANTIFICATION IN ENZYME-LINKED IMMUNOSORBENT-ASSAY OF A C-3 NEOEPITOPE EXPRESSED ON ACTIVATED HUMAN-COMPLEMENT FACTOR-C3 [J].
GARRED, P ;
MOLLNES, TE ;
LEA, T .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 27 (03) :329-335